# HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

> **NCT01520272** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 376 (actual)

## Conditions studied

- HPV16 Anitbody Levels Post Vaccination
- HPV18 Antibody Levels Post Vaccination

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01520272
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-02
- **Primary completion:** —
- **Final completion:** 2017-06-28
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520272, "HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01520272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*